Vaccine extends glioblastoma patients’ survival in phase II trial
Wednesday, October 6, 2010 - 08:20
in Health & Medicine
HOUSTON - A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in...
